ProfileGDS5678 / 1435374_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 17% 10% 50% 23% 15% 16% 16% 17% 17% 35% 26% 16% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4208516
GSM967853U87-EV human glioblastoma xenograft - Control 22.4198417
GSM967854U87-EV human glioblastoma xenograft - Control 32.2491910
GSM967855U87-EV human glioblastoma xenograft - Control 43.1473950
GSM967856U87-EV human glioblastoma xenograft - Control 52.4887123
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4318715
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4178516
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3844416
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.384617
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4111617
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.791135
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.561826
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3872516
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.7246132